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Abstract
Background: There is often a huge gap between neurobiological facts and firm conclusions stated by the media. Data
misrepresentation in the conclusions and summaries of neuroscience articles might contribute to this gap.
Methodology/Principal Findings: Using the case of attention deficit hyperactivity disorder (ADHD), we identified three
types of misrepresentation. The first relies on prominent inconsistencies between results and claimed conclusions and was
observed in two scientific reports dealing with ADHD. Only one out of the 61 media articles echoing both scientific reports
adequately described the results and, thus questioned the claimed conclusion. The second type of misrepresentation
consists in putting a firm conclusion in the summary while raw data that strongly limit the claim are only given in the results
section. To quantify this misrepresentation we analyzed the summaries of all articles asserting that polymorphisms of the
gene coding for the D4 dopaminergic receptor are associated with ADHD. Only 25 summaries out of 159 also mentioned
that this association confers a small risk. This misrepresentation is also observed in most media articles reporting on ADHD
and the D4 gene. The third misrepresentation consists in extrapolating basic and pre-clinical findings to new therapeutic
prospects in inappropriate ways. Indeed, analysis of all ADHD-related studies in mice showed that 23% of the conclusions
were overstated. The frequency of this overstatement was positively related with the impact factor of the journal.
Conclusion/Significance: Data misrepresentations are frequent in the scientific literature dealing with ADHD and may
contribute to the appearance of misleading conclusions in the media. In synergy with citation distortions and publication
biases they influence social representations and bias the scientific evidence in favor of the view that ADHD is primarily
caused by biological factors. We discuss the social consequences and the causes of data misrepresentations and suggest a
few corrective actions.
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Introduction
‘‘The problems often start with how research findings are
presented to the public’’ said Prof G. McKhann [1]. Indeed, all
neuroscientists have in mind ‘‘flashy stories’’ where media have
presented weak or controversial findings as established conclu-
sions. As in other fields of biomedical research journalists [2]
and press releases [3] certainly contribute to this misrepresen-
tation. Moreover, citation distortions and publications biases,
which have been described in biomedical research [4–7]
including neuroscience [8], also contribute to create unfounded
authority of claims. Here, we point out the misrepresentation of
the neurobiological facts at its initial level, i.e. inside individual
scientific articles. Indeed, a fair and constructive debate requires
that ‘‘authors are obligated to present their data in a form that
minimizes the chance that readers will be misled about what
was actually observed.’’ (Guide of the Society For Neuroscience:
‘‘Responsible Conduct Regarding Scientific Communication’’,
paragraph 1.13.2). We show how a n dt ow h a te x t e n tt h i se t h i c a l
commitment is not fulfilled in many neuroscience articles. As
stated by Prof McKhann, data misrepresentation is an ethical
concern for the neuroscience community: ‘‘If our advances
are repeatedly overstated or over-promoted and public distrust
of neuroscience grows, then we have only ourselves to
blame.’’
ADHD is considered to be the most common neuropsychiatric
disorder of childhood with a prevalence rate of approximately 7–
9%. Psychostimulants effectively alleviate symptoms in most
ADHD children. Hundreds of studies have investigated the
neurobiology of ADHD and numerous hypotheses have been
proposed. The dopamine deficit theory is still the most popular
one [9] although it has been questioned by others [10] and in our
recent review article [11]. In the present study we do not question
the data regarding ADHD and the validity of their interpretation.
We examine how data are presented in scientific and media
articles.
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and cases of data misrepresentation. Therefore, we will mainly
defend our view using the example of ADHD. However, there is
no reason to think that data misrepresentation occurs only, or is
worst, in this particular field. We identified three types of
misrepresentation in the scientific literature about ADHD. The
first relies on prominent inconsistencies between results and
conclusions claimed in the title and summary. The second consists
in putting a firm conclusion in the summary while raw data that
strongly limit the claim are only given in the results section. In the
third, basic and pre-clinical findings are extrapolated to new
therapeutic prospects in inappropriate ways. Here, we illustrate
each type of misrepresentation by analyzing scientific and media
articles reporting on specific topics related to ADHD. Then, we
discuss the social consequences and the causes of these
misrepresentations. Finally, we suggest a few remedies.
Results
Internal inconsistencies
In our review of the ADHD literature [11], we have read about
360 articles and we have found only two studies showing obvious
discrepancies between results and claimed conclusions [12,13].
These internal inconsistencies have already been discussed in
detail [11] and are summarized in Table 1. Our observation that
only two articles among 360 show obvious internal inconsistencies
must be considered with caution however. First, our review of the
ADHD literature was not a systematic one and was not aimed at
pointing out internal inconsistencies. Second, generalization to
other fields of the neuroscience literature would be unjustified. We
can only say that our observations confirm our intuition: this first
type of misrepresentation is, fortunately, infrequent.
The point of interest here is that both articles have been echoed
in the media as shown in Table 1. The media almost always
reported on the claimed conclusion. Indeed, concerning the article
by Volkow et al (2007), we have checked 40 media articles and the
conclusion that dopamine is depressed in the brain of ADHD
patients has been always reported. We have never read a
mitigating statement saying that their results are open to the
opposite interpretation although the authors explicitly raised this
possibility in their result section (Table 1). In our sample of 21
articles that reported on the study by Barbaresi et al (2007) in the
media, only one (The Guardian, London, September 21, 2007)
adequately described the results and, thus questioned the
conclusion claimed by Barbaresi’s group (Table 1).
More surprisingly, the scientific literature is no more critical.
BetweenitspublicationandFebruary2010thestudybyVolkowetal
(2007) has been cited 30 times in scientific articles. Among them, 20
articles cited the conclusion that dopamine activity is depressed in
ADHD without further comment. Apart from our review article
[11], none of them pointed out its internal inconsistency.
Fact omission
This misrepresentation consists of putting in the summary a
fixed conclusion while raw data, which strongly limit the relevance
of this conclusion, are only given in the result section. To quantify
this misrepresentation, we have extensively studied how the
scientific literature reports on a specific issue: the association
between alleles of the gene coding for the D4 dopamine receptor
(DRD4) and ADHD.
To fully appraise this misrepresentation it is illuminating to
compare a statement in the media and the corresponding facts. The
health guide of the New York Times says: ‘‘Genetic factors may play
the most important role in ADHD…. Most of the research on the
underlying genetic mechanisms targets the neurotransmitter dopa-
mine. Variations in genes that regulate specific dopamine receptors
have been identified i nah i g hp r o p o r t i o no fp e o p l ewith ADHD.’’
Table 1. In two articles showing internal inconsistencies only the claimed conclusion is echoed in the media.
Article title Depressed dopamine activity in caudate and preliminary
evidence of limbic involvement in adults with
attention-deficit/hyperactivity disorder. (Volkow et al., 2007)
Modifiers of long-term school outcomes for children with
attention-deficit/hyperactivity disorder: does treatment with
stimulant medication make a difference? (Barbaresi et al., 2007)
Claim in the article ‘‘These results provide evidence of depressed dopamine
activity in ADHD.’’… ‘‘The findings of reduced dopamine
release in subjects with ADHD are consistent with the notion
that the ability of stimulant medications to enhance extracellular
dopamine underlies their therapeutic effects in ADHD.’’
‘‘This study supports the hypothesis that treatment with
stimulant medication is associated with more favorable,
long-term school outcomes for children with ADHD.’’
Facts questioning
the claim (article
citations)
‘‘D2/D3 receptor availability was significantly lower in subjects with
ADHD…Since measures of D2/D3 availability are influenced by
extracellular dopamine, low Bmax could reflect either increased dopamine
release or low D2/D3 receptor levels.’’ ‘‘We cannot rule out the possibility
that the blunted dopamine response to methylphenidate in subjects with
ADHD could reflect higher baseline dopamine tone.’’
‘‘The average reading score at the time of the last assessment
was similar between the groups of cases that were treated
versus not treated with stimulant.’’ ‘‘The proportion of school
dropout was similar between treated and not treated cases.’’
Newspapers
Title
‘‘Brain chemicals have key role in ADHD, studies show’’.
(The Wall Street Journal, August 7, 2007)
‘‘ADHD drugs help boost children’s grades’’
(Washington Post, September 21, 2007)
citation ‘‘A team led by Dr. Nora Volkow, director of the NIH’s National
Institute on Drug Abuse, documented decreased dopamine
activity in the brains of a group of adults with ADHD. Volkow
said the decreased dopamine activity related to systems
involved with attention and cognition, but also with reward.’’
‘‘This is the first study that shows that taking stimulants
for ADHD improves long-term school performance,’’
said lead researcher Dr. William Barbaresi.’’
Medical website:
title
ADHD appears to be associated with depressed dopamine
activity in the brain. (http://www.docguide.com)
ADHD stimulant drug therapy helps improve long-term
school outcomes. (http://www.news-medical.net)
citation ‘‘The findings of reduced dopamine release in subjects with
ADHD are consistent with the notion that the ability of
stimulant medications to enhance extracellular dopamine
underlies their therapeutic effects in ADHD,’’ the authors write.
‘‘In this study, treatment with stimulant medication during
childhood was associated with more favorable long-term
school outcomes,’’ explains William Barbaresi,
doi:10.1371/journal.pone.0014618.t001
Misrepresenting Data into News
PLoS ONE | www.plosone.org 2 January 2011 | Volume 6 | Issue 1 | e14618Actually, ‘‘the most robust finding in ADHD is the association of a
variable number tandem repeat polymorphism in exon 3 of the
DRD4 gene’’ [14]. However, although the 7-repeat allele is
significantly associated with ADHD, it confers small risk [15]:
ADHDpatientshaveahigher frequencyofthisalleleas compared to
controls, 23% versus 17%, respectively [16]. Therefore, there is a
hugegapbetweenthemediastatementandtheneurobiologicalfacts.
This gap is generated when scientific texts report the association of
the 7-repeat allele of the DRD4 gene with ADHD but do not
mention at the same time that it confers small risk.
To quantify this misrepresentation in the scientific literature, we
examined the summaries of all 219 articles about ADHD that
mentioned the DRD4 gene. Articles were classified between
review articles (52), animal (or in vitro) studies (24) and research
articles in humans (143). This third category was further divided
into articles, in which genetic data related to the DRD4 were
provided (117) or not (26). In this second category, as well as in
animal studies, statements related to the association of the DRD4
gene with ADHD thus corresponded to citations of other articles.
In these 219 summaries we counted the presence of specific
statements as indicated in Table 2.
Among the 117 primary studies in humans, 74 articles state in
their summary that alleles of the DRD4 genes are significantly
associated with ADHD but only 19 summaries also mentioned
that they confer a small risk. One may argue that summaries are
too short to report the details. However, almost the same number
of summaries (14) did not mention that it confers small risk but
reinforced the view that genetic factors play the most important
role in ADHD with an additional statement about its high
heritability. Moreover, this misrepresentation always occurs in the
summaries of primary articles that cite the association of the
DRD4 gene with ADHD but do not report data on it (Table 2).
This misrepresentation is even more robust in review articles.
Among the 43 relevant summaries stating that the DRD4 gene is
significantly associated with ADHD only 6 mentioned that the 7-
repeat allele confers a small risk. Again one may argue that this is
due to length constraints, but this explanation is not consistent
with other observations. Indeed, 13 summaries did not mention
that it confers a small risk but added a statement on the high
heritability of ADHD. Likewise, 9 summaries also mentioned the
following type of erroneous statement: ‘‘The efficacy of stimulant
agents confirms that the neurotransmitter abnormalities seen in
ADHD are primarily catecholaminergic in origin.’’ The weakness
of this argument has long been underlined [11,17,18] and relies on
the fact that psychostimulants enhance attention to the same
extent both in ADHD and healthy children [17].
On the whole, the case of the association between ADHD and
the DRD4 gene shows that the omission of relevant facts limiting
the impact of the claim is not restricted to a few scientific articles: it
occurs in a vast majority of the summaries. Although in most
reports and review articles, the raw data (e.g. odds ratios) were
given inside the results section, it is likely that many readers may
not check inside the text the relevance of the statement put in the
summary (‘‘the DRD4 gene is associated with ADHD’’).
This misrepresentation is also observed in media articles. Indeed,
we looked for press articles reporting on the DRD4 gene and on
ADHD. Among 170 relevant articles published from 1996 to 2009, all
but 2 stated that polymorphisms of the DRD4 gene are significantly
associated with ADHD. Twenty-five articles also mentioned either the
raw data or that it confers small risk, while 117 articles did not.
Furthermore, 26 articles mentioned the odds ratio (from 1.2 to 1.34)
but also put an overstated conclusion (e.g. ‘‘These findings strongly
implicate the involvement of brain dopamine systems in the
pathogenesis of ADHD.’’). Thus, the 26 equivocal articles being
discarded, 82% of the media articles misrepresented the association
between the DRD4 gene and ADHD. This omission rate is very
similar to that observed in scientific articles (Table 2).
The literature on the association between the DRD4 gene and
ADHD further exemplifies a major publication bias: the most
robust effectsarereported ininitial studies [5]. Indeed, althoughthis
association is still considered to be highly statistically significant, its
odds ratio decreased with successive studies from 2.4 in the oldest
study in 1996 [19] to reach 1.27 in the most recent meta-analysis
[15]. This decrease in the clinical relevance of this association is not
correlated with parallel changes in type-2 misrepresentation.
Indeed, omission rates both in scientific and media articles did
not decrease over the years 1996 to 2009 (Table S1).
Extrapolating basic and pre-clinical findings to new
therapeutic prospects
This third type of misrepresentation is illustrated with three
examples concerning ADHD (Table 3). Unjustified overstatements
Table 2. Content analysis of the summaries of scientific articles containing ‘‘ADHD’’ and ‘‘D4’’ or ‘‘DRD4’’.
Statements Review articles Animal studies Human studies*
citation data
Total number of articles 52 24 26 117
1) DRD4 gene is associated with ADHD 37 17 25 55
2) DRD4 gene is associated but it confers small risk 6 0 0 19
3) DRD4 is not associated with ADHD 1 1 0 27
4) Not relevant 8 6 1 16
Ratio (small risk)/(DRD4 associated) i.e. (1/1+2) 6/43 0/17 0/25 19/74
Omission rate: (1-ratio) 6100 86% 100% 100% 74%
*Human studies were divided into articles providing data on the DRD4 gene (‘‘data’’) or not (‘‘citation’’).
The presence of the following statements was numbered.
1) ‘‘DRD4 associated with ADHD’’. In these articles, the association of the DRD4 gene with ADHD is stated as an established fact.
2) ‘‘DRD4 gene is associated but it confers small risk’’. In these articles the first statement is mitigated by either mentioning raw data (e.g. odds ratio) or by stating that the
DRD4 gene confers small risk to ADHD.
3) ‘‘DRD4 is not associated with ADHD’’. These articles defend the view that the association of ADHD with the DRD4 gene does not reach statistical significance.
4) ‘‘Not relevant’’. In these articles the summary was not informative enough to know whether the authors defend the view that the DRD4 gene is associated with ADHD.
doi:10.1371/journal.pone.0014618.t002
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an example, we examined a survey of all ADHD-related studies
reporting data from the mouse brain. We rated a study as
overstated when the link between ADHD and the studied mice
only relied on their behavioral similarities with ADHD symptoms
and when the conclusion stated that the findings provide novel
insights into the neurobiology of ADHD (see Methods). Indeed,
because ADHD is a very complex disease associated in most
patients with other psychiatric disorders (e.g. anxiety, depression,
conduct disorders), investigations based on mouse behavior cannot
capture the ADHD complexity. From our survey of 101 articles we
found that only 45 were not overstated and that 23 studies also
extrapolate to new therapeutic prospects. These 23 overstated
studies were published in journals with a significantly higher
impact factor (Fig. 1A–B). When they are published in high rank
journals these overstatements are often echoed in the media as
exemplified in Table 3. We examined 63 media articles that
echoed the 3 articles mentioned in Table 3. We observed that they
faithfully reported these 3 overstatements although a few (11/63)
also added a comment that mitigated it (see two examples in
Table 3).
Discussion
Limitations of the study
Using the case of ADHD, we investigated 3 types of data
misrepresentation in scientific articles: internal inconsistencies,
omission of relevant facts and unjustified extrapolation to new
therapeutic prospects. The first type was illustrated with only two
scientific reports and this selection does not result from a
systematic search. Therefore, our observations cannot give a
quantitative estimate of the prevalence of this misrepresentation.
The second and the third types of misrepresentation were each
illustrated with only one specific aspect of the ADHD literature. In
both cases we analyzed a corpus of scientific reports selected by a
systematic search. Therefore, our study is mainly qualitative and
does not provide quantitative information about the extent of data
misrepresentation in the ADHD literature as a whole.
Our examples of data misrepresentation in scientific reports
seem to be correlated with similar misrepresentation in the lay
media. Thus, we speculate that data misrepresentation in the
scientific literature might play a part in the distortion of data into
misleading conclusions in the media. In support of our hypothesis,
we observed that many lay articles either cite the conclusions
stated in scientific articles or report interviews of the scientific
authors.
Data misrepresentation, citation distortion and
publication bias
Data misrepresentations in the summaries and conclusions seem
to spread in media articles. Indeed, we noticed only a few
discrepancies between the conclusions stated in scientific articles
and how they are echoed in the media. Overstatements to
therapeutic prospects are faithfully reported although some
reservations are sometimes expressed. As previously suspected
Table 3. Examples of extrapolating basic findings to new therapeutic prospects and their echoes in the media.
Science:
Title
Dopamine transporter density in patients
with attention deficit hyperactivity disorder.
Role of serotonin in the paradoxical calming effect
of psychostimulants on hyperactivity.
Impulsive choice induced in rats by
lesions of the nucleus accumbens core.
Ref. Lancet (1999) [26] Science (1999) [27] Science (2001) [28]
over-
statement
‘‘The dopamine transporter in brain,
a major target of the majority of drugs
used to treat ADHD, was elevated by a
bout 70% compared to healthy controls.
The use of
129I altropane SPECT could be
expanded to individualize treatment.’’
‘‘The preponderance of common symptomatologies
between DAT-KO mice and individuals with ADHD
suggests that these mice may not only serve as a
useful animal model and as a resource to test new
therapies but that they may also provide insights
into the basic mechanisms that underlie the etiology
of this and other hyperkinetic disorders.’’
‘‘Impulsive choice contributes to drug
addiction, ADHD… Thus, dysfunction
of the nucleus accumbens core may
be a key element in the
neuropathology of impulsivity.’’
comment This study was based on only 6 adults
with ADHD. Whether the DAT level is
altered in ADHD patients is still a
matter of debate (see [29]).
DAT-KO mice are calmed by psychostimulants via
the inhibition of the serotonin transporter. However,
specific inhibitors of the serotonin transporter do
not alleviate ADHD symptoms [30,31].
A recent meta-analysis ‘‘do not support
simpler models which posit that ADHD is
strictly a disorder resulting from deficits of
activity in a few isolated brain regions’’ [32].
Media:
Title
Brain scans seen as test in attention
disorder
Findings: Better attention deficit drugs possible Pleasing find on gratification.
source The Boston Globe The Washington Post Financial Times
date December 17, 1999 January 15, 1999 May 25, 2001
citation Brain scans have identified a clear-cut
chemical abnormality in people with
ADHD, …It could be a first step toward
a long-sought test for attention- deficit
hyperactivity disorder, say researchers.
I tm a yb ep o s s i b l et od e s i g nb e t t e rd r u g sf o rt r e a t i n g
ADHD, which affects millions of children in the United
States, researchers said yesterday. Tests on mice show
that stimulant drugs currently used to treat the disorder,
such as Ritalin and amphetamines, work in a more complex
way than previously thought, the researchers said.
The discovery could help research into
drug addiction, attention-deficit disorder,
hyperactivity and other personality
disorders that are marked by inability to
control instant gratification.
Mitigating
citation
‘‘This is certainly not yet a diagnostic
test,’’ because it involved a ‘‘very refined
sample’’ of patients who aren’t represen-
tative of the entire spectrum of those who
have the disorder, Barkley said.
The researchers did not, however, measure serotonin
levels in the mice. And mice are physically very
different from humans and often react differently
to drugs.
*Number
of articles
35 (including 9 mitigating comments) 20 (2 mitigating comments) 8 (no mitigating comment)
*In this last row we give the number of media articles obtained using a systematic search (see Methods) that echoed the corresponding scientific articles. In parentheses
we indicate the number of media articles that added a mitigating statement.
doi:10.1371/journal.pone.0014618.t003
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statement to therapeutic prospects is positively correlated with
publication in leading journals. In the biomedical literature,
scientific articles, which are echoed in the media, are more likely to
be cited in subsequent scientific articles [21]. These circular
relationships may explain why these overstatements are advanta-
geous both for authors and editors.
Citation distortion has been already studied in detail regarding a
specific neurobiological claim [8]. We also observed several case of
citation distortion in the ADHD literature. For example, the facts
that psychostimulants both alleviate symptoms in most ADHD
children and enhance the extracellular dopamine level have
repeatedly been put forward to support the dopamine deficit
theory of ADHD. However, this inference is rarely mitigated by
also mentioning that psychostimulants induce the same behavioral
effects in healthy children [17].
We also observed in the ADHD literature several examples of a
major publication bias: the most robust effects are reported in
initial studies. This publication bias has already been pointed out
in the biomedical literature [4,5] and is obvious regarding the
association of ADHD either with the DRD4 gene or with the
density of the dopamine transporter. Here we show that data
misrepresentation reinforces this publication bias in both scientific
and media articles. Indeed, whereas subsequent studies diminish
the odds ratio and thus, the clinical relevance of the initial study,
the rate of type-2 misrepresentation (omitting to mention relevant
data) does not decrease with time.
Although most journal guidelines explicitly condemn them, data
misrepresentations, citation distortions and publication biases are
frequent in the neuroscience literature. They ‘‘provide a distorted
view of the reality of scientific data’’ and reinforce ‘‘dominant
themes [that] lead to stagnating conformism’’ [7]. Regarding the
neurobiology of ADHD, although histamine neurons do play a
role in attention, it is striking to note that the number of studies on
dopamine (1314) dramatically exceeds those on histamine (38)
(PubMed March 2010, key words: ADHD, dopamine, histamine).
Review articles are expected to provide a wider and more
balanced view of a theme. Unfortunately, most review articles tend
to confine themselves to consensual points of view [8]. In
conclusion, we believe that neuroscientists contribute to distorting
data into misleading conclusions in the media. However, most
neuroscientists do not seem to be conscious that these distortions
have social consequences.
Social and public health consequences
There is no doubt that ADHD is a real concern in the sense that
most ADHD diagnosed individuals suffer from attention deficit
and excessive impulsivity. According to Singh (2008) there are
three partially overlapping positions in the public debate about
ADHD. The first one posits that ADHD is primarily caused by
biological factors, the second that ADHD is caused by a
combination of biological and social factors and the third that
ADHD is primarily caused by environmental factors [22]. The
first position is not consistent with data demonstrating that
environmental factors play a role in ADHD (low economic status,
severe child mistreatment, maternal smoking during pregnancy,
premature birth, teenager pregnancy and other environmental
adversities) [22].
Unfortunately, data misrepresentation biases the scientific
evidence in favor of the first position stating that ADHD is
primarily caused by biological factors. Therefore, this misrepre-
sentation does have social consequences regarding ADHD
management: it favors medical interventions over prevention
and psycho-social interventions. Moreover, the first position favors
research programs that seek to identify biomarkers associated with
an ADHD risk. Although no biomarker has yet been already
validated in psychiatry, ‘‘the current interest in biomarkers is a
sign that psychiatry has undergone a methodological shift, away
from searching for the causes of a condition towards estimating the
probability that the condition is present or will develop’’ [23].
Figure 1. Overstatement of the relevance of mouse studies towards ADHD neurobiology and treatment. Studies were selected with a
systematic search via PubMed (see methods). We rated a study as overstated when the link between ADHD and the studied mice only relied on their
behavioral similarities with ADHD symptoms and when the conclusion stated that the findings provide novel insights into the neurobiology of ADHD.
When this overstatement was reinforced by a claim about the clinical relevance of the study, it was rated as of type 2. Among the 101 studies
examined, 56 were classified as overstated (33 type 1 and 23 type 2). A. Relationship between these 3 classes and the impact factor of the
corresponding journal. Horizontal bars indicate mean 6 SEM for the 3 classes. This impact factor was significantly higher (ANOVA, F=6.52, Fisher’s
test: *p=0.0006) when comparing studies with the type 2 overstatement to studies without overstatement. B. The occurrence rate of extrapolating
to new therapeutic prospects (type 2 overstatement) is positively related to the impact factor.
doi:10.1371/journal.pone.0014618.g001
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medical interventions that focus on individual-level risk factors
rather than on social and environmental risk factors’’ [23].
Likewise, the neuroscience discourse about depression biases the
public debate in favor of biological causes and promotes the use of
antidepressants [18,24]. This excessive support of the medicaliza-
tion of psychic suffering induces counter-reactions promoting
alternative responses such as psychotherapies, but also often leads
to suspicious attitudes towards neuroscience and might promote
irrational beliefs and conducts in society.
The social consequences also depend on the type of misrepre-
sentation. The first type (internal inconsistencies) and the second
(omission of significant facts) do have large consequences when
they are echoed in the media. Indeed, they corrupt the message
received by the general public, including medical doctors. The
third type (exaggerated extrapolations to therapeutic prospects)
seems at first glance the least damaging. However, when it occurs
in animal studies, it implicitly supports the view that drug
treatments are the only solution to mental disorders. Indeed,
animal models are not suitable to develop psycho-social interven-
tions. Moreover, and probably far more damaging in the long
term to neuroscience, this misrepresentation feeds illusory short-
term hopes in patients and their families. For example, animal
studies about cellular therapies for spinal cord injury have been
put forward by for-profit institutions selling these therapies to
unfortunate patients although ‘‘these interventions are not yet
proven safe and effective by properly conducted clinical trials’’
[25]. Extrapolation of basic findings to therapeutic prospects never
acknowledges the lag time of 10 to 15 years needed for making a
novel treatment available to the public, even should the concept be
further validated in subsequent studies. Examples of such
overstatements are far too abundant to be listed and basically
apply to all neurological and psychiatric conditions.
Causes of data misrepresentation
Most neuroscientists believe that extrapolating their basic
finding to new therapeutic prospects will help their study to be
published in a high impact factor journal. Accordingly, our study
of the case of ADHD suggests that this type of overstatement is
positively associated with publication in prestigious journals.
Although it is difficult to know whether this association is causal,
there is no neuroscience journal, to our knowledge, stating in their
instructions to authors that extrapolation to therapeutic prospects
is acceptable only if fully justified. More generally, competition
between authors to publish in high rank journals and between
journal editors distorts publication of biomedical research in favor
of sensationalism [7]. Pressures to publish in leading journals have
been already discussed and include careerism and evaluation of
science by bibliographic indicators [20].
Moreover, neuroscience is closely linked to related medical
sciences, neurology, psychiatry and neuropharmacology. National
research agencies increasingly restrict their support to research
projects with potential applications in these 3 medical domains.
Therefore, neuroscientists are encouraged to work in line with this
institutional demand and to preferentially publish positive results.
Even when they are published, negative results or data challenging
established dogma are often ignored both by the scientific
literature and by the media as exemplified here. Data misrepre-
sentation, citation distortion and publication biases feed the
information cascades, which are circularly used to justify the
hypotheses put forward in grant proposals [8]. ‘‘Once research
funding has been used to join a cascade there are further incentives
to interpret results through confirmation bias to demonstrate
success of the research for subsequent funding’’ [8].
Solutions
First, because our pioneer study is mainly qualitative, we need
more studies analyzing the neuroscience discourse. These studies
must receive sufficient visibility to draw the attention of the
neuroscience community to the extent of data misrepresentation
and to its negative consequences. As neuroscience findings are
increasingly echoed by the media, we are now, and much more so
than in the past, in the public eye. Distortions of neuroscience
findings open the door to suspicious public attitudes towards
neuroscience and this might result in a decrease of the resources
that society will accept being allocated to future research. It is the
responsibility of the neuroscience community, and in its long-term
interest, to correct this as soon as possible. Second, the key
regulators of our publication system are the journal editors. If they
collectively reject sensationalism and clearly condemn data
misrepresentation, we may expect rapid improvement. This might
involve changes in current publication practices as suggested
[7,20]. Third, the neuroscience community should lobby in favor
of research grants without any link to therapeutic applications.
This lobbying should explain to politicians that an excessive
support of therapeutically oriented research programs is counter-
productive because it favors herding research and encourages
misinformation of the lay public.
Methods
Sources of data
Our analysis was restricted to scientific articles published in
English in journal issues whose publication year was 2009 or
earlier. Articles without abstracts were not considered. They were
collected from PubMed by means of systematic searches, except
for the two articles analyzed in the first section ‘‘Internal
inconsistencies’’. Both articles were found on the occasion of a
previous review article about the neurobiology of ADHD. Because
this previous work was not a systematic review and because our
aim was not to carefully look for all articles exhibiting internal
inconsistencies between their results sections and conclusions, both
articles represent examples of internal inconsistencies. In other
words our study does not provide a reliable quantitative estimate
of this particular type of data misrepresentation. In the same
section we used the site ‘‘ISI Web of Knowledge’’ to find the 30
scientific articles citing the study by Volkow et al (2007). Because
only 8 studies cited the article by Barbaresi et al (2007), we did not
analyze them.
In the third section of the results entitled ‘‘Extrapolating basic and
pre-clinical findings to new therapeutic prospects’’ the impact factor of
scientific journals was provided by ‘‘ISI Web of Knowledge’’ using
the tool ‘‘Journal Citation Reports’’. We used the impact factors
given by this tool for 2008.
Articles published in English in newspapers and magazines were
systematically searched using the web site ‘‘Dow Jones Factiva’’
(http://global.factiva.com/sb/default.aspx?NAPC=S&fcpil=fr)
and appropriate key words, whose presence was searched in the
full texts. Primary scientific articles also given by this database
were discarded. When very similar articles were published in
distinct newspapers or magazines they were considered as
distinct articles. Articles published on web sites did not originate
from a systematic search and were found using ‘‘Google’’ and
appropriate key words.
Data selection and classification
Articles published in newspapers, magazines or web sites and
reporting either on the study by Volkow et al (2007) or on that by
Barbaresi et al (2007) (Table 1) were found using the following key
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ADHD). The search periods were restricted to articles published
in August, September and October 2007. The corresponding
reference lists are given in Text S1. We examined these 61 articles
to determine whether they only reported on the claimed
conclusion.
We examined the summaries of scientific articles that
mentioned ADHD and the DRD4 gene. Articles were selected
via PubMed using the following equation applied to all fields:
(attention deficit hyperactivity disorder OR ADHD) AND (D4
OR DRD4). From the 235 retrieved articles we discarded 16
articles whose abstracts did not mentioned DRD4. The remaining
219 summaries were classified as described in Table 2. The
corresponding reference lists are given in Text S2, according to
that classification.
Articles published in newspapers and magazines from January
1996 to January 2010 were selected using the following criteria:
hyperactivity AND (D4 OR DRD4). Articles, which were not
informative enough to know whether the authors have defended
the view that the DRD4 gene is associated with ADHD were
discarded. The 170 remaining articles were examined and
classified according to the same rules as described in Table 2.
The classified lists of references are given in Text S2.
All articles related to ADHD and reporting on experiments
involving the mouse brain were selected via PubMed with the
following search equation applied to all fields using the PubMed
limit ‘‘animals’’: (attention deficit hyperactivity disorder OR
ADHD) AND (mouse OR mice). This search retrieved 178
articles published in 2009 or earlier. We discarded 58 review
articles, 16 studies that reported observations not related to the
mouse brain and 3 studies not related to ADHD. In the 101
selected articles we examined the conclusions stated in the
summary and at the end of the discussion. We rated a study as
overstated when the link between ADHD and the studied mice
only relied on their behavioral similarities with ADHD symptoms
and when the conclusion stated that the findings have provided
novel insights into the neurobiology of ADHD. When this
overstatement was reinforced by a claim about the clinical
relevance of the study, it was rated as of type 2. Studies, which
were considered as not overstated, belonged to 3 types: i) mice
submitted to experimental conditions mimicking those causally
involved in ADHD (e.g. lead toxicity, maternal deprivation), ii)
investigations into the effects of psychostimulant treatments on the
mouse brain and iii) studies on mouse models of ADHD, in which
authors refrained from overstating their conclusion. This classifi-
cation was double-checked independently by two investigators.
The classified lists of references are given in Text S3.
Using the web site ‘‘Dow Jones Factiva’’ we looked for media
articles explicitly reporting on the three scientific studies
mentioned in Table 3 by Dougherty et al (1999), Gainetdinov et
al (1999) and Cardinal et al (2001). The search criteria were
(hyperactivity OR ADHD) combined either with (scans OR scan),
with (mice) or with (Cardinal OR rats), respectively. The search
periods were 3 month long and started one day before the date of
online publication of the corresponding scientific article. Using this
procedure we have collected 63 media articles explicitly echoing to
the 3 corresponding scientific articles (Table 3). After collection of
these 63 media articles, each article was compared to the
overstatement expressed in the corresponding scientific article.
The classified lists of references are given in Text S3.
Supporting Information
Table S1 Distribution of the omission rate with the publication
year.
Found at: doi:10.1371/journal.pone.0014618.s001 (0.04 MB
DOC)
Text S1 Lists of media and scientific articles echoing the studies
by Volkow et al (2007) and Barbaresi et al (2007) shown in Table 1.
Found at: doi:10.1371/journal.pone.0014618.s002 (0.08 MB
DOC)
Text S2 Scientific and media articles reporting on the associa-
tion between alleles of the gene coding for the D4 dopamine
receptor and ADHD.
Found at: doi:10.1371/journal.pone.0014618.s003 (0.14 MB
DOC)
Text S3 Scientific studies performed in mice and related to
ADHD and media articles that echoed to the 3 scientific articles
given in Table 3.
Found at: doi:10.1371/journal.pone.0014618.s004 (0.08 MB
DOC)
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